Hypoparathyroidism in Clinical Practice: Improving Patient Outcomes for Better Quality of Life

New Orleans, LA US

Monday, March 25, 2019
Hilton New Orleans Riverside, Grand Ballroom AB
Registration/Dinner: 5:45 – 6:15 pm | Program: 6:15 – 8:15 pm

This course is a live CME-certified Ancillary Symposium presented at ENDO 2019, held in New Orleans, LA. This educational activity is supported by an independent medical educational grant from Shire through a collaboration between the Endocrine Society and Medscape Education. These ancillary symposia are developed through the Endocrine Society’s Special Programs Committee (SPC).








Target Audience

This activity is intended for endocrinologists, surgeons, primary care physicians, and other healthcare professionals attending ENDO 2019 involved in the care of patients who have hypoparathyroidism. 

Learning Objectives

Upon completion of this educational activity, learners will be able to:

Have increased knowledge regarding the

  • Challenges faced by endocrinologists related to diagnosis and management of hypoparathyroidism
  • New data related to safety, efficacy, and impact on quality of life (QoL) of pharmacotherapy options for hypoparathyroidism

Have greater confidence in their ability for

  • Early recognition and diagnosis of hypoparathyroidism
  • Safe and effective management of hypoparathyroidism in acute and chronic settings
  • Improvement of QoL for patients with hypoparathyroidism

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Medical Knowledge
Topic Area: 
Bone and Calciotropic Hormones
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Available credit: 
  • 2.00 ABIM MOC
  • 2.00 AMA PRA Category 1 Credits
  • 2.00 CME Certificate of Participation
Course opens: 
Course expires: 
Hilton New Orleans Riverside, Grand Ballroom AB
2 Poydras St
New Orleans, LA 70130
United States

Program Chair

Dolores M. Shoback, MD
Professor of Medicine
University of California of San Francisco
VA Medical Center
San Francisco, CA


Bart Lyman Clarke, MD
Professor of Medicine
Mayo Clinic
Rochester, MN

Michael Mannstadt, MD
Associate Professor
Harvard University
Endocrine Unit Chief
Massachussetts General Hospital 
Boston, MA



The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Dolores M. Shoback, MD: consultant, Ascendis Pharma A/S, Shire
Bart Lyman Clarke, MD: Consultant, shire; Clinical Research, Shire; Research Investigator, shire
Michael Mannstadt, MD: consultant, shire; spouse, employee of Radius Health, INC.

The following SPC member who planned and reviewed content for this activity reported relevant financial relationships: 
Steven T. Harris, MD: Ad hoc consultant on Advisory Boards, Eli Lilly & Company, Radius Health; Speaker, Amgen, Eli Lilly & Company, Radius Health

The following SPC members reported relevant financial relationships:
Andrew Ahmann, MD:Research Support, Dexcom, Medtronic; Consultant, Dexcom, Eli Lilly & Company, Horizon CME, MannKind, Novo Nordisk, Sanofi; Speaker, Horizon CME; Principle Investigator, National Institute of Health, T1D Exchange, Trial Net
Giuseppe Barbesino, MD: Advisory Boards, Horizon Pharmaceuticals, Ipsen Pharmaceuticals; Spouse, employee of Genzyme
Joan Han, MD:Research Support, Rhythm Pharmaceuticals; Principle Investigator, Insys Therapeutics, Rhythm Pharmaceuticals
Jonathan Purnell, MD: Advisor, Novo Nordisk
Neda Rasouli, MD:Research Support, Novo Nordisk, Boehringer Ingelheim, Rhythm Pharmaceuticals, Elira Therapeutics; Consultant, Intarcia
Amy Rothberg, MD:Spouse, consultant of Merck
Susmeeta Sharma, MD: Speaker, Corcept

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:
Beret Ann Casey, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Click "Start" to complete the meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit™ and 2.0 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact



Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 


Review your Diplomate ABIM ID Number(s)

In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  1. Provide your board-certification information in your educational profile.  Your profile currently contains the following board ID numbers (must be logged in to view):

    Your ABIM Number: [current-user:profile-profile:field-number-abim]*

    *If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.

  2. Update Profile

Available Credit

  • 2.00 ABIM MOC
  • 2.00 AMA PRA Category 1 Credits
  • 2.00 CME Certificate of Participation